What Is The Prevalence Of Methicillin-Resistant Staphylococcus Au- Reus (MRSA) In Intensive Care Units Across Urban Hospitals ? : A Systematic Review
Keywords:
MRSA, Prevalence, Intensive Care Unit, Urban Hospitals, Infection Control, ColonizationAbstract
Introduction: Methicillin-resistant Staphylococcus aureus (MRSA) remains a significant pathogen in healthcare settings, particularly in intensive care units (ICUs) where patients are highly vulnerable due to compromised immune systems and invasive procedures. The prevalence of MRSA in ICUs shows wide variation, ranging from 0% to 98.4%, influenced by factors such as geographic location, ICU type, and screening Methods: This systematic review adhered strictly to the Preferred Reporting Items for Systematic Review and Meta-Analysis (PRISMA) 2020 guidelines to ensure methodological rigor. Results: Forty studies were included in this systematic review. The reported MRSA prevalence rates varied widely, ranging from 0% to 98.4%. Specific rates included 81.5% in one study and 1.2% for colonization in another, with infection rates as low as 0.212%. Temporal trends showed declining rates in some regions (e.g., 7.9% with a declining trend from 2014-2020), while others reported no significant long-term change. Factors impacting prevalence included ICU type, refugee status, patient age, and decolonization practices. Discussion: The considerable heterogeneity in reported MRSA prevalence highlights the influence of diverse settings, patient populations, and definitions of MRSA (colonization vs. infection). Data specific to urban hospitals were limited, with most studies lacking detailed urban/rural breakdowns. This complicates direct comparisons and limits the generalizability of findings to all urban ICUs. Conclusion: MRSA prevalence in urban ICUs is highly variable, influenced by various factors including ICU type and patient characteristics. Further research with standardized reporting and a clearer urban/rural distinction is needed to inform targeted infection control strategies.
References
Arunava Saha, and Erin E O'SHEA PAUDEL. “MRSA NASAL SCREEN IN THE SETTING OF UNIVER- SAL DECOLONIZATION: AN EMERGING DIAGNOSTIC DILEMMA.” Chest, 2023.
———. “Nasal Methicillin-Resistant Staphylococcus Aureus Culture Screens in the Setting of Universal Decolonization.” Infectious Diseases in Clinical Practice, 2023.
Blanca Anaya-Baz, Natalia Maldonado, Zaira R Palacios-Baena, V. Palomo, M. Pezzani, Sheila Chiesi, E. Razzaboni, M. Compri, E. Tacconelli, and J. Rodríguez-Baño. “Systematic Literature Review of the Burden and Outcomes of Infections Due to Multidrug-Resistant Organisms in Europe: The ABOUT- MDRO Project Protocol.” BMJ Open, 2020.
Chang Liu, Jianguo Li, and Z. Peng. “681: AEROSOLIZED AMIKACIN AS ADJUNCTIVE THERAPY OF VAP CAUSED BY MDR-GNB.” Critical Care Medicine, 2016.
D. Morgan. “Choosing Between Methods to Prevent Methicillin-Resistant Staphylococcus Aureus in ICUs*.” Critical Care Medicine, 2015.
Diane M. Parente, C. Cunha, E. Mylonakis, and T. Timbrook. “The Clinical Utility of Methicillin-Resistant Staphylococcus Aureus (MRSA) Nasal Screening to Rule Out MRSA Pneumonia: A Diagnostic Meta- Analysis With Antimicrobial Stewardship Implications.” Clinical Infectious Diseases, 2018.
Ha Yeon Kim, W. Lee, S. Na, Y. Roh, C. Shin, and Jeongmin Kim. “The Effects of Chlorhexidine Gluconate Bathing on Health Care-Associated Infection in Intensive Care Units: A Meta-Analysis.” Journal of Critical Care, 2016.
Hsu-Liang Chang, Tzu-Ying Liu, Po-Shou Huang, Chin-Hwan Chen, Chia-Wen Yen, Hui-Zhu Chen, Shin- Huei Kuo, Tun-Chieh Chen, Shang-Yi Lin, and Po-Liang Lu. “Implementation of 2% Chlorhexidine Bathing to Reduce Healthcare-Associated Infections Among Patients in the Intensive Care Unit.” Mi- croorganisms, 2025.
J. Suh, Namsick Kim, M. Lee, Seoung Eun Lee, B. Chun, C. Lee, Juneyoung Lee, et al. “Real-World Experience of How Chlorhexidine Bathing Affects the Acquisition and Incidence of Vancomycin-Resistant Enterococci (VRE) in a Medical Intensive Care Unit with VRE Endemicity: A Prospective Interrupted Time-Series Study.” Antimicrobial Resistance and Infection Control, 2021.
James Hurley. “Rebound Inverts the Staphylococcus Aureus Bacteremia Prevention Effect of Antibiotic Based Decontamination Interventions in ICU Cohorts with Prolonged Length of Stay.” Antibiotics, 2024.
Jisu Seo, and R. Song. “[Effect of 2% Chlorhexidine Bathing on the Incidence of Hospital-Acquired Infection and Multidrug-Resistant Organisms in Adult Intensive Care Unit Patients: Systematic Review and Meta-Analysis].” Journal of Korean Academy of Nursing, 2021.
Jufang Sun, Dewei Qian, Ren Zhou, Rongrong Tang, Lichun Guan, Yizhou Ye, Ying Pu, and Min Yu. “Effects of Preoperative Staphylococcus Aureus Screening and Targeted Decolonization Bundle Protocols in Cardiac Surgery: A Nine-Year Review of a Regional Cardiovascular Center in China.” Journal of Thoracic Disease, 2022.
K. Khader, Alun Thomas, W. Huskins, M. Leecaster, Yue Zhang, T. Greene, A. Redd, and M. Samore. “A Dynamic Transmission Model to Evaluate the Effectiveness of Infection Control Strategies.” Open Forum Infectious Diseases, 2017.
Kevin Doan, and S. Smoke. “Antibiotic de-Escalation in Pneumonia with Pharmacist Education and Order- ing of Methicillin-Resistant Staphylococcus Aureus Nasal Swabs.” European Journal of Hospital Phar- macy: Science and Practice, 2023.
Lina Meng, S. Pourali, M. Hitchcock, David R Ha, Emily Mui, W. Alegria, C. Diep, et al. “1489. Safety and Performance of a Pharmacist-Driven Nasal MRSA PCR Protocol for De-Escalation of Empiric Van- comycin for Suspected Pneumonia at an Academic Medical Center,” 2020.
M. Dadashi, Bahareh Hajikhani, D. Darban-Sarokhalil, A. van Belkum, and M. Goudarzi. “Mupirocin Resistance in Staphylococcus Aureus: A Systematic Review and Meta-Analysis.” Journal of Global Antimicrobial Resistance, 2020.
M. Gerlich, Jens Piegsa, C. Schäfer, N. Hübner, F. Wilke, Susanne Reuter, G. Engel, et al. “Improving Hospital Hygiene to Reduce the Impact of Multidrug-Resistant Organisms in Health Care–a Prospective Controlled Multicenter Study.” BMC Infectious Diseases, 2015.
M. Hayden, K. Lolans, K. Haffenreffer, Taliser R. Avery, K. Kleinman, Haiying Li, Rebecca E. Kaganov, et al. “Chlorhexidine and Mupirocin Susceptibility of Methicillin-Resistant Staphylococcus Aureus Isolates in the REDUCE-MRSA Trial.” Journal of Clinical Microbiology, 2016.
M. Kitahara, S. Takayama, T. Akaishi, Akiko Kikuchi, and T. Ishii. “Hochuekkito Can Prevent the Col- onization of Methicillin-Resistant Staphylococcus Aureus in Upper Respiratory Tract of Acute Stroke Patients.” Frontiers in Pharmacology, 2021.
M. Shams-Abadi, M. Halaji, S. Hoseini-Alfatemi, A. Gholipour, A. Mojtahedi, and Hadi Sedigh Ebrahim- Saraie. “Epidemiology of Toxic Shock Syndrome Toxin-1 Harboring Staphylococcus Aureus Obtained from Clinical Samples in Iran: A Systematic Review and Meta-Analysis.” Annali Di Igiene : Medicina Preventiva e Di Comunita, 2018.
Maria Rödenbeck, Olaniyi Ayobami, T. Eckmanns, M. W. Pletz, J. Bleidorn, and R. Markwart. “Clinical Epidemiology and Case Fatality Due to Antimicrobial Resistance in Germany: A Systematic Review and Meta-Analysis, 1 January 2010 to 31 December 2021.” Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin, 2023.
Melanie N Smith, A. Brotherton, K. Lusardi, Carrie A. Tan, and Drayton A. Hammond. “Systematic Review of the Clinical Utility of Methicillin-Resistant Staphylococcus Aureus (MRSA) Nasal Screening for MRSA Pneumonia.” The Annals of Pharmacotherapy, 2019.
Mohammed Obeidat, Mahmoud Alwakeel, Abdelrahman Nanah, Fatima Abdeljaleel, D. Alayan, Miguel MEJIA MORALES, F. Abi Fadel, and Mohamed K. A. Awad. “ASSESSMENT OF NASAL POLY- MERASE CHAIN REACTION FOR METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS (MRSA) IN THE DIAGNOSIS OF MRSA PNEUMONIA IN INTENSIVE CARE UNIT.” Chest, 2023.
N. Raush, Kevin D. Betthauser, K. Shen, Tamara Krekel, and M. Kollef. “Prospective Nasal Screening for Methicillin-Resistant Staphylococcus Aureus in Critically Ill Patients With Suspected Pneumonia.” Open Forum Infectious Diseases, 2021.
P. Moise, Darren L. Culshaw, A. Wong-Beringer, Joyce Bensman, K. Lamp, Winter J Smith, Karri A. Bauer, et al. “Comparative Effectiveness of Vancomycin Versus Daptomycin for MRSA Bacteremia With Vancomycin MIC >1 Mg/L: A Multicenter Evaluation.” Clinical Therapeutics, 2016.
P. Patel, J. Meddings, D. Calfee, K. Popovich, Jeffrey M. Rohde, Andrew J. Rolle, K. Fowler, et al. “2469. A National Intervention to Improve Infection Prevention Efforts in Hospitals with High Rates of Clostrid- ioides Difficile Infection, Central Line-Associated Bloodstream Infection, Catheter-Associated Urinary Tract Infection and/or Methicillin-Resistant Staphylococcus Aureus.” Open Forum Infectious Diseases, 2019.
R. Fulchini, W. Albrich, A. Kronenberg, A. Egli, C. Kahlert, M. Schlegel, and P. Kohler. “Antibiotic- Resistant Pathogens in Different Patient Settings and Identification of Surveillance Gaps in Switzerland – a Systematic Review.” Epidemiology and Infection, 2019.
R. Nahra, Shahrzad Darvish, Snehal Gandhi, Suzanne Gould, Diane Floyd, Kathy Devine, Henry S Fraimow, J. E. Dibato, and J. Rachoin. “Impact of Povidone Application to Nares in Addition to Chlorhexidine Bath in Critically Ill Patients on Nosocomial Bacteremia and Central Line Blood Stream Infection.” Journal of Clinical Medicine, 2024.
Ross Pineda, M. Kanatani, and J. Deville. “102. Effects of an Antimicrobial Stewardship-Guided MRSA Nasal Screening Review on Vancomycin Utilization for Respiratory Infections: A Quasi-Experimental Study,” 2020.
Ruhana Che Yusof, M. N. Norhayati, and Yacob Mohd Azman. “Bacterial Coinfection and Antibiotic Resistance in Hospitalized COVID-19 Patients: A Systematic Review and Meta-Analysis.” PeerJ, 2023.
S. Frost, Mari-Cris Alogso, Lauren Metcalfe, Joan M. Lynch, L. Hunt, R. Sanghavi, E. Alexandrou, and K. Hillman. “Chlorhexidine Bathing and Health Care-Associated Infections Among Adult Intensive Care Patients: A Systematic Review and Meta-Analysis.” Critical Care, 2016.
Shanshan Zhang, Xiaoxi Sun, Wenjiao Chang, Yuanyuan Dai, and Xiaoling Ma. “Systematic Review and Meta-Analysis of the Epidemiology of Vancomycin-Intermediate and Heterogeneous Vancomycin- Intermediate Staphylococcus Aureus Isolates.” PLoS ONE, 2015.
Shawn Alderman, Crystal R. Heishman, and Richard Skiff. “739. Impact of Alcohol-Based Nasal Decolo- nization’s Method of Documentation in Reducing Methicillin-Resistant Staphylococcus Aureus Hospital- Associated Infections.” Open Forum Infectious Diseases, 2023.
Stephanie Kreiling, Rachel Watson, Gabriela Perez, Adrienne Carr, and Rachel M Wolfe. “1199. Implemen- tation of a Nasal Antiseptic Decolonization Program Reduces the Occurrence of Healthcare-Associated Infections in the Adult Intensive Care Unit Setting.” Open Forum Infectious Diseases, 2022.
Susan S. Huang, E. Septimus, K. Kleinman, Lauren T Heim, J. Moody, Taliser R. Avery, L. McLean, et al. “4. 137 Hospital Cluster-Randomized Trial of Mupirocin-Chlorhexidine Vs Iodophor-Chlorhexidine for Universal Decolonization in Intensive Care Units (ICUs) (Mupirocin Iodophor Swap Out Trial).” Open Forum Infectious Diseases, 2021.
T. Khan, Y. L. Kok, A. Bukhsh, Learn‐Han Lee, Kok-Gan Chan, and B. Goh. “Incidence of Methicillin Resistant Staphylococcus Aureus (MRSA) in Burn Intensive Care Unit: A Systematic Review.” GERMS, 2018.
W. Bischoff, James P Viviano, G. Russell, and John R. Stehle. “Lifting Contact Precautions for Methicillin- Resistant Staphylococcus Aureus (MRSA) Isolation: Effect on MRSA Infection Measures,” 2016.
W. W. Lim, P. Wu, H. Bond, J. Wong, Kaiwen Ni, W. Seto, M. Jit, and B. Cowling. “Determinants of Methicillin-Resistant Staphylococcus Aureus (MRSA) Prevalence in the Asia-Pacific Region: A System- atic Review and Meta-Analysis.” Journal of Global Antimicrobial Resistance, 2019.
Z. Mirza, A. Bardossy, Helina Misikir, Hind Hadid, Nathalie Baratz, H. Rizvi, E. Herc, Anne Y. Chen, and M. Zervos. “1208. Impact of Admission to an Inpatient Infectious Disease Unit on Methicillin-Resistant Staphylococcus Aureus Bloodstream Infections.” Open Forum Infectious Diseases, 2018.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Gabriella Selara Pangarepo, Fenny (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors publishing here keep copyright but grant the journal first publication rights, under a Creative Commons Attribution-NonCommercial 4.0 License. They can distribute their work non-exclusively elsewhere with an acknowledgment of its first publication in this journal. Posting the work online before and during submission for earlier and greater citation is encouraged, reflecting Open Access benefits.
